Preablation Diagnostic Whole-Body Scan vs Empiric Radioactive Iodine Ablation in Differentiated Thyroid Cancer: Cost-effectiveness Analysis

Ralf Paschke, Thomas Lincke, Stefan P. Müller, Michael C. Kreissl, Henning Dralle, Martin Fassnacht, The Treatment of Well-Differentiated Thyroid Carcinoma Deutsches Arzteblatt International. ,vol. 112, pp. 452- 458 ,(2015) , 10.3238/ARZTEBL.2015.0452

J.Robert Beck, Stephen G. Pauker, Jonathan E. Gottlieb, Karen Klein, Jerome P. Kassirer, A convenient approximation of life expectancy (the “DEALE”): II. Use in medical decision-making The American Journal of Medicine. ,vol. 73, pp. 889- 897 ,(1982) , 10.1016/0002-9343(82)90787-2

Massimo Salvatori, Germano Perotti, Vittoria Rufini, Maria Lodovica Maussier, Massimo Dottorini, Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan? Clinical Endocrinology. ,vol. 61, pp. 704- 710 ,(2004) , 10.1111/J.1365-2265.2004.02153.X

Douglas Van Nostrand, Martha Aiken, Frank Atkins, Shari Moreau, Carlos Garcia, Elmo Acio, Kenneth Burman, Leonard Wartofsky, The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer. Thyroid. ,vol. 19, pp. 849- 855 ,(2009) , 10.1089/THY.2008.0419

AjitS Shinto, DeepuK Shibu, K Vyshak, Joppy Antony, KK Kamaleshwaran, Empiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number? World journal of nuclear medicine. ,vol. 12, pp. 61- 64 ,(2013) , 10.4103/1450-1147.136694

Beng Khiong Yap, Brian Murby, No Adverse Affect in Clinical Outcome Using Low Preablation Diagnostic 131I Activity in Differentiated Thyroid Cancer: Refuting Thyroid-Stunning Effect The Journal of Clinical Endocrinology and Metabolism. ,vol. 99, pp. 2433- 2440 ,(2014) , 10.1210/JC.2014-1405

Peter J Neumann, Joshua T Cohen, Milton C Weinstein, None, Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold New England Journal of Medicine. ,vol. 371, pp. 796- 797 ,(2014) , 10.1056/NEJMP1405158

Françoise Aubène Leger, Mireille Izembart, Françoise Dagousset, Lionel Barritault, Georges Baillet, Alain Chevalier, Jérôme Clerc, Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 25, pp. 242- 246 ,(1998) , 10.1007/S002590050223

Ji Min Han, Won Gu Kim, Tae Yong Kim, Min Ji Jeon, Jin-Sook Ryu, Dong Eun Song, Suck Joon Hong, Young Kee Shong, Won Bae Kim, Effects of Low-Dose and High-Dose Postoperative Radioiodine Therapy on the Clinical Outcome in Patients with Small Differentiated Thyroid Cancer Having Microscopic Extrathyroidal Extension Thyroid. ,vol. 24, pp. 820- 825 ,(2014) , 10.1089/THY.2013.0362

David S. Cooper, Gerard M. Doherty, Bryan R. Haugen, Richard T. Kloos, Stephanie L. Lee, Susan J. Mandel, Ernest L. Mazzaferri, Bryan McIver, Furio Pacini, Martin Schlumberger, Steven I. Sherman, David L. Steward, R. Michael Tuttle, Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer Thyroid. ,vol. 19, pp. 1167- 1214 ,(2009) , 10.1089/THY.2009.0110